{"transactions":[{"id":4085017,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":82089,"kind":"person","name":"BAYER AKTIENGESELLSCHAFT","position":1,"cik":"0001144145","reported_name":"BAYER AKTIENGESELLSCHAFT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":169979,"kind":"organization","name":"Bayer Global Investments B.V.","position":2,"cik":"0001685417","reported_name":"Bayer Global Investments B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-01-30T14:21:21.000Z","date":"2018-01-05","kind":"purchase","acquired":true,"shares":527472,"price":22.75,"value":11999988.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents purchase by Bayer Global Investments B.V. (\"Bayer BV\").  Bayer BV is the Direct Owner of 5,632,802 common shares of CRISPR Therapeutics AG (\"CRISR\").  This Form 4 is a joint filing of Bayer BV and Bayer AG.  Bayer AG is the 100% Indirect Owner through subsidiaries of the same shares as to which Bayer BV is the Direct Owner."}],"balance_after":5632802,"source":{"system":"sec-edgar","filing":"0000029905-18-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1144145/000002990518000006/edgar.xml","form_type":"4"}}]}